Leading generics pharmaceutical company
More drugs are in short supply for longer periods of time due to a fundamentally flawed pharmaceutical supply chain, according to a new report. The number of ongoing drug shortages has increased from 2017 to 2018 after declining from a peak in 2011. Shortages have also been lasting longer, in some cases more than eight […]
Consumer Reports examines why prescription drug prices are rising so sharply—and how to lower your drug costs As consumers, we know the difference between products we want and products we need. For luxury or convenience items, it’s easy enough to hold off on a purchase if our budget demands it—but for the things we can’t […]
“Costly branded medicines are a factor in driving up the cost of insurance”! Expensive branded medicines prescribed by doctors are driving up the cost of healthcare for insurers and employers, experts have said. Insurers said too many physicians are sending patients home with bags of unnecessary drugs. The issue is a factor in a new […]
Cost of branded drugs almost 14% below average in 50 countries surveyed Irish patients pay over six times the international average for generic drugs while branded medicines cost less than the average, according to a new survey. Ireland has the lowest price for the erectile dysfunction drug Viagra of the 50 countries included in the […]
According to the Association for Accessible Medicines 2019 report with data from IQVIA, generic drug savings totaled $293 billion in 2018, which resulted in a 10-year savings of almost $2 trillion. Other key findings include that 4 billion generic prescriptions were filled across the U.S. in 2018, which is 90% of all dispensed prescriptions. Additionally, 95% of […]
Medicare could have saved nearly 90% of spending on angiotensin converting enzyme inhibitors and angiotensin-II-receptor blockers in 2016 and 2017 through generic substitute or therapeutic interchange, according to study results published in JAMA Internal Medicine. “Prescription drug spending accounts for an increasing share of U.S. health care costs.” Mathew E. Growdon, MD, MPH, of the […]
As per the study conducted by Journal of Drug Delivery and Therapeutics, about 62% of healthcare providers want to substitute generic drugs but not for all the cases they treat, thus indicates the perception of the efficacy of the two classes of medicines. With the escalating cost of healthcare facilities, many people in India […]
BARCELONA — In 2014, ViiV Healthcare, a pharmaceutical company dedicated to ending the HIV epidemic, and the Medicines Patent Pool, an organization funded primarily by Unitaid to increase access to medicines in lower-income countries, signed two voluntary licensing agreements. The agreements allowed generic manufacturers to produce and sell low-cost versions of the ViiV-developed HIV drug dolutegravir in all low- […]
It’s pretty much just two women who name the 200-plus drugs that come out every year Generic prescriptions allow patients to get the medicines they need at a lower price, without sacrificing the quality of treatment because, as we know, generic drugs are required by the FDA to be nearly identical to their name-brand […]
Effective 1 July 2019, the EU adopted a regulation by introducing a supplementary protection certificate (SPC) manufacturing and stockpiling waiver. This waiver also applies for biosimilar versions of SPC-protected medicine during the term of the SPC. SPC’s are defined as IP rights extending patent protection for up to five years for medicines that are […]
